Stay updated on Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.4) was added to the study record history, replacing the previous v3.6.3 and signaling a minor metadata update.
    Difference
    0.1%
    Check dated 2026-07-21T12:48:43.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    A new revision entry v3.6.3 was added to the study record history, and the older v3.6.0 entry was removed.
    Difference
    0.1%
    Check dated 2026-06-30T01:57:45.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added 'Last verified' and 'Last known status was' fields to the record history and updated the revision label to 'Revision: v3.6.0' to reflect the latest data verification and versioning.
    Difference
    2%
    Check dated 2026-06-15T19:13:32.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The record history shows Revision: v3.5.5 replacing Revision: v3.5.4, indicating a new build/version of the ClinicalTrials.gov history interface.
    Difference
    0.1%
    Check dated 2026-06-08T16:27:21.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Added a new revision entry (v3.5.4) to the Study Record Versions, replacing the previous v3.5.3. This updates the revision history for the study.
    Difference
    0.1%
    Check dated 2026-05-18T04:00:25.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov interface revision indicator has been updated from v3.5.0 to v3.5.3, reflecting a change to the site/versioning rather than the underlying trial history or study information.
    Difference
    0.1%
    Check dated 2026-04-26T15:23:12.000Z thumbnail image

Stay in the know with updates to Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page.